6月26日 - ** 膳食补充剂生产商Nature's Sunshine Products NATR.O股价下跌9.8%，最新跌幅为6.1%，报13.93美元。
** 总部位于美国犹他州利希市的NATR宣布二次发行定价 (link)，由复星医药美国公司以每股12美元的价格出售约290万股，募集资金总额为3430万美元。
** 定价较股票最后收盘价折价19
** 作为发行的一部分，NATR 同意以发行价向承销商购买最多 1,500 万美元的股票
** D.A. Davidson 是此次发行的唯一簿记管理人
** 根据 (link) 招股说明书，复星医药是 NATR 的第一大股东，持股 15.5%。
** 覆盖该股的所有两家券商均将其评为 "买入"；PT 中位数为 20 美元--数据由 LSEG 编制
** 截至上次收盘，NATR 股价年累计上涨 1.2
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.